. Author manuscript; available in PMC: 2018 Apr 1.

Published in final edited form as: Hematol Oncol Clin North Am. 2017 Apr;31(2):317–334. doi: 10.1016/j.hoc.2016.11.006

TABLE 1.

CD30+ Lymphocytic Disorders

Neoplastic	Lymphomatoid papulosis (LyP) Primary cutaneous anaplastic large cell lymphoma (pcALCL) br1>Systemic cutaneous anaplastic large cell lymphoma (scALCL) Mycosis fungoides or Sezary syndrome with CD30+ large cell transformation Cutaneous Hodgkin’s disease CD30+ large B-cell lymphoma Epstein Barr virus (EBV)+ hydroa vacciniforme-like T-cell lymphoma Human T-cell Lymphotropic virus type 1 (HTLV-1) associated adult T-cell lymphoma/leukemia Eruptive keratoacantomas
Exogeneous	Drug-induced reactive lymphoid hyperplasia^{44,45,46,47,48,49,} Insect bite reaction⁵⁰ Scabies infestation⁵¹
Infection associated	EBV⁵² HTLV-1/2 Mycobacteria⁵³ Herpes simplex virus (HSV)⁵⁰ Human immunodeficiency virus⁵⁴ Other infections: leishmaniasis, syphilis, varicella zoster virus, molluscum contagiosum virus and parapox virusError! Bookmark not defined.
Inflammatory conditions	Pityriasis lichenoides Pityriasis lichenoides et varioliformis acuta Pityriasis lichenoides chronica Eruption of lymphocyte recovery⁵⁵ Atopic dermatitis⁵⁶

Adapted from: LeBoeuf NR, McDermott S, Harris NL. Case records of the Massachusetts General Hospital. Case 5–2015. A 69-year-old woman with recurrent skin lesions after treatment for lymphoma. N Engl J Med. 2015 Feb 12;372(7):650–9, with permission.